RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+9.61%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.63B
AUM Growth
+$6.63B
(+3.5%)
Cap. Flow
-$77.8M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
45.03%
Holding
125
New
14
Increased
22
Reduced
8
Closed
12
Top Buys
| 1 |
ESSA Pharma
EPIX
|
$79.1M |
| 2 |
Masimo
MASI
|
$56.1M |
| 3 |
Regenxbio
RGNX
|
$52.1M |
| 4 |
GH Research
GHRS
|
$42.7M |
| 5 |
Guardant Health
GH
|
$38.3M |
Top Sells
| 1 |
CERN
Cerner Corp
CERN
|
$128M |
| 2 |
Arvinas
ARVN
|
$107M |
| 3 |
Immunovant
IMVT
|
$102M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$72.3M |
| 5 |
Curis
CRIS
|
$41M |
Sector Composition
| 1 | Healthcare | 88.48% |
| 2 | Financials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
26
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $76M | 1.15% |
3,264,031
| – | – |
|
27
IDEAYA Biosciences
IDYA
$2.26B
| $68.6M | 1.03% |
3,266,255
+800,000
| +32% | +$16.8M |
|
28
MacroGenics
MGNX
$121M
| $68.4M | 1.03% |
2,546,925
+532,525
| +26% | +$14.3M |
|
|
29
Regenxbio
RGNX
$498M
| $68.3M | 1.03% |
1,757,743
+1,341,166
| +322% | +$52.1M |
|
|
AGEN
30
Agenus
AGEN
$136M
| $62.8M | 0.95% |
582,727
-119,224
| -17% | -$12.8M |
|
31
Castle Biosciences
CSTL
$673M
| $58.6M | 0.88% |
799,009
| – | – |
|
32
Tarsus Pharmaceuticals
TARS
$2.44B
| $58.4M | 0.88% |
2,013,601
-450,000
| -18% | -$13M |
|
|
NSTG
33
DELISTED
NanoString Technologies, Inc.
NSTG
| $52.1M | 0.79% |
804,029
| – | – |
|
34
Pulmonx
LUNG
$67.6M
| $49.8M | 0.75% |
1,129,600
| – | – |
|
35
Relmada Therapeutics
RLMD
$48.8M
| $49.2M | 0.74% |
1,538,026
+7,309
| +0.5% | +$234K |
|
|
LABP
36
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $48.5M | 0.73% |
427,572
| – | – |
|
37
Immunocore
IMCR
$1.78B
| $47.9M | 0.72% |
1,245,532
| – | – |
|
|
ITOS
38
DELISTED
iTeos Therapeutics
ITOS
| $44M | 0.66% |
1,716,585
-1,046,206
| -38% | -$26.8M |
|
39
ProQR Therapeutics
PRQR
$256M
| $43.4M | 0.66% |
6,443,113
+19,035
| +0.3% | +$128K |
|
|
OLK
40
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $43M | 0.65% |
1,248,188
+1,062,350
| +572% | +$36.6M |
|
|
41
GH Research
GHRS
$870M
| $42.7M | 0.64% |
+2,168,957
| New | +$42.7M |
|
|
ISEE
42
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $42.4M | 0.64% |
6,722,624
| – | – |
|
43
Cytokinetics
CYTK
$5.98B
| $39.6M | 0.6% |
2,000,000
| – | – |
|
|
AVDL
44
Avadel Pharmaceuticals
AVDL
$1.45B
| $38.6M | 0.58% |
5,741,939
| – | – |
|
45
Outset Medical
OM
$245M
| $36.8M | 0.56% |
49,143
+3,333
| +7% | +$2.5M |
|
|
GTH
46
DELISTED
Genetron Holdings Limited ADS
GTH
| $36.6M | 0.55% |
606,054
| – | – |
|
|
CUTR
47
DELISTED
Cutera, Inc.
CUTR
| $35.3M | 0.53% |
+720,817
| New | +$35.3M |
|
48
Apyx Medical
APYX
$71.9M
| $35M | 0.53% |
3,391,279
| – | – |
|
49
MiMedx Group
MDXG
$1.05B
| $33.8M | 0.51% |
2,700,320
| – | – |
|
50
Fulcrum Therapeutics
FULC
$353M
| $33.6M | 0.51% |
3,205,291
| – | – |
|